PDCD1 and myeloid sarcoma: Moreover, an intronic 7146G/A polymorphisms within the PD-1 gene, which result in reduced inhibitory function of PD-1 on cytokine production and T-cell activation, are associated with a progressive disease course in MS patients (Kroner et al., 2005).